Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The PDT/Lucentis trial will be a Phase IV comparative trial comparing the use of combination
therapy with ITV ranibizumab and verteporfin PDT to ITV ranibizumab alone in patients with
exudative AMD.